Project Grant P30AG092752
Award Date
6/15/25
Completion Date
3/31/30
Dollars Obligated
$4.7M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
The National Institute on Aging (NIA), part of the Department of Health and Human Services National Institutes of Health, awarded a $3.37 million Project Grant to The University of Texas at Arlington to develop an individualized deep connectome framework for Alzheimer's disease and related dementias (ADRD) analysis. The three-year grant, awarded on August 18, 2022 under the NIA's Aging Research program (CFDA 93.866), will support research to discover and identify individualized...
The National Institute on Aging, part of the Department of Health and Human Services' National Institutes of Health, awarded $3,724,674 under the Aging Research program (CFDA 93.866) to Texas Tech University Health Sciences Center in Lubbock, Texas. The three-year project grant beginning September 15, 2022 will support research into the impacts of microrna-455-3p (miR-455-3p) in Alzheimer's disease. Specifically, the grantee will investigate the neuroprotective effects of overexpressing and...
The National Institute on Aging (NIA) awarded a Project Grant (CFDA 93.866 - Aging Research) in the amount of $661,016 to the University of Southern California (USC) to develop a "Federated Deep Learning to Accelerate Alzheimer's Disease Research" project. The key products and services to be delivered include: Establishing an international "Federate AD" alliance to leverage innovative AI techniques and distributed computation to study Alzheimer's disease (AD) across large,...
This $310,000 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research by Texas Tech University Health Sciences Center (TTUHSC) to examine how alternative polyadenylation (APA) of mRNAs contributes to the development and progression of Alzheimer's disease (AD). The project has two main goals: 1) to identify APA genes and pathways associated with AD pathology using computational analysis of existing single-cell RNA-sequencing datasets, and 2)...
This $2,919,399 five-year Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) supports a comprehensive study investigating cerebral tau deposition and comorbid cerebrovascular disease in Mexican American older adults across the Alzheimer's disease continuum. The primary awardee, the University of Texas Health Science Center at San Antonio, will develop and validate advanced tau positron emission tomography (PET) imaging biomarkers and evaluate their associations...
This Project Grant award of $654,238 from the National Institute on Aging (CFDA 93.866 Aging Research program) supports research to identify the role of senescent neurons in brain aging and Alzheimer's disease and related dementias (ADRD). The primary awardee, the University of Texas Health Science Center at San Antonio, will generate spatial omics data from ADRD brains and mouse models, while the co-investigator team at Washington University will provide expertise in experimental design, data...
The National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) Federal Grant Program, has awarded a $103,304 project grant to the University of Southern California (USC) to investigate cell-type susceptibility to Alzheimer's disease (AD) pathology. The 1-year project, effective August 1, 2024, will use advanced viral tracing methods, microscopy imaging, and spatial transcriptomics to identify vulnerable neuron cell types within the medial temporal lobe and characterize the...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), provides $2,858,766.00 to The University of Texas Health Science Center at San Antonio to conduct research on the role of L-type calcium channels (LTCCs) in Alzheimer's disease pathophysiology. The key objectives are to: Evaluate the contribution of neuronal and microglial LTCCs to endo-lysosomal dysfunction during amyloid pathology in Alzheimer's disease. Assess the peripheral...
This $6,226,692 Project Grant awarded by the National Institute on Aging (NIA) under the Aging Research (CFDA 93.866) program supports research examining the role of neuronal hyperexcitability and proteostasis in the progression of Alzheimer's disease (AD). The study aims to use a mouse model to investigate how modifications in brain activity, specifically in the locus coeruleus (LC) and hippocampus (HPC), can lead to the pathological hallmarks of AD. Key objectives include tracking early...
This Project Grant award of $1,859,444, provided by the National Institute on Aging (NIA) under the Aging Research (CFDA 93.866) program, supports research at the University of Texas Health Science Center at San Antonio (UTHSCSA) investigating the role of the lipid sulfatide in the development of tau pathology in Alzheimer's disease and related dementias. The research aims to determine how sulfatide deficiency leads to increased tau phosphorylation and aggregation in oligodendrocytes, and...